MASIMO CORP (MASI) Stock News
NASDAQ:MASI - Nasdaq - US5747951003 - Common Stock - Currency: USD
MASI Latest News, Press Relases and Analysis
Masimo (MASI) Q1 Earnings Report Preview: What To Look For
Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings tomorrow after market close. Here’s what investors should know.
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up
Tandem Diabetes' Q1 bottom line lags estimate. However, the company experiences strong sales growth both in and outside the United States.
BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket
Bio-Rad witnesses first-quarter top-line decline in its Life Science segment, primarily due to challenges in the academic research market.
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts. Shares rise in pre-market.
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y
Accuray reports solid fiscal third-quarter results, witnessing growth in Product & Services revenues and reduced operating expenses.
Here's Why You Should Add Veeva Stock to Your Portfolio Now
VEEV's robust product portfolio and a slew of strategic deals raise optimism about the stock.
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline
Glaukos' first-quarter results showcase a strong uptick in revenues. However, continued operating loss remains a cause of concern.
CAH Q3 Earnings Beat Estimates, '25 EPS View Raised, Stock Gains
Cardinal Health's third-quarter fiscal 2025 results benefit from solid Medical and Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market
IDEXX delivers year-over-year earnings and revenue growth in the first quarter of 2025.
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook
CNMD reports solid first-quarter results, driven by improving sales across both segments.
ECL Stock Up in Pre-Market Following Q1 Earnings Meet Estimates
Ecolab's robust performance across the majority of its segments drives its first-quarter organic sales despite business challenges.
EMEA Growth & Product Launches to Support Boston Scientific Stock
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.
Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up
DGX delivers solid top-line growth in the first quarter of 2025.
Why You Shouldn't Bet Against Masimo (MASI) Stock
Masimo (MASI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Should You Continue to Hold Veracyte Stock in Your Portfolio?
Strength in the Afirma and Decipher franchises continues to bode well for VCYT stock.
RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up
Revvity's first-quarter results showcase strong growth in Diagnostics business, along with recovery in Life Sciences segmental sales.
Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y
AVTR's Bioscience Production segment witnesses robust growth amid macroeconomic pressures.
HSIC Gears Up for Q1 Earnings: Here's What You Need to Know
Henry Schein is expected to report impressive Q1 2025 sales in each of its business segment and a positive pace of recovery from the cyber incident.
EPD Growth in Emerging Market Supports Abbott Stock Amid Macro Woes
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit
West Pharmaceutical's first-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.
Penumbra Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Expand
PEN reports better-than-expected earnings and revenues in the first quarter of 2025.
Reasons to Hold TNDM Stock in Your Portfolio for Now
A robust diabetes market and international expansion raise investors' optimism for Tandem Diabetes.
Thermo Fisher's Q1 Earnings Top Estimates, Revenues Beat, Stock Up
TMO continues to advance its growth strategy and trusted partner status with customers in the first quarter of 2025.
ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts
ISRG's first-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.
BSX Q1 Earnings & Revenues Beat, Stock Up, 2025 View Raised
Boston Scientific's first-quarter 2025 performance benefits from the strength of its product portfolio.
Concentra Stock Slips Despite Deal to Acquire Pivot Onsite Innovations
CON is set to acquire Pivot Onsite Innovations, expanding its onsite occupational health services and strengthening its national footprint in workforce health solutions.
Zimmer Biomet to Report Q1 Earnings: Here's What to Expect
ZBH's Hips business is expected to have witnessed growth on the back of its suite of navigation solutions in direct anterior stems and surgical impactors.
Is Coca-Cola Company (KO) the Best Performing Long Term Stock So Far in 2025?
We recently published a list of 10 Best Performing Long Term Stocks So Far in 2025. In this article, we are going to take a look at where The Coca-Cola Company (NYSE:KO) stands against other best performing long term stocks so far in 2025. Consumer morale fell more drastically than expected in April, owing to […]
Sonoco Products Company (SON): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025
We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Sonoco Products Company (NYSE:SON) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets tumbled on Wednesday, with technology shares leading the slide amid growing […]
Why Masimo (MASI) Could Beat Earnings Estimates Again
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ALGN Gears Up for Q1 Earnings: What Lies Ahead for the Stock?
Align Technology's first-quarter 2025 results are likely to reflect the strength in its Clear Aligner business.
Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings
EW's first-quarter 2025 performance is likely to have gained from growth drivers across its businesses amid macroeconomic headwinds.
Will a Strong MA Business Aid Elevance Health's Q1 Earnings?
ELV's Q1 results are expected to reap the benefits of higher premiums from growing Medicare Advantage membership and acquisitions pursued within the Carelon unit.
Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market
ABT delivers a strong underlying base business performance for the first quarter of 2025.
Is it the Right Time to Hold STERIS Stock in Your Portfolio?
STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment.
Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth
LH's first-quarter 2025 performance is likely to have benefited from both its Dx and BLS businesses.